253 related articles for article (PubMed ID: 27227698)
1. Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma.
McDonald WC; Banerji N; McDonald KN; Ho B; Macias V; Kajdacsy-Balla A
Arch Pathol Lab Med; 2017 Jan; 141(1):104-112. PubMed ID: 27227698
[TBL] [Abstract][Full Text] [Related]
2. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
[TBL] [Abstract][Full Text] [Related]
3. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
4. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
5. Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic factor-1 messenger RNA expression in pituitary tumors.
McDermott MT; Haugen BR; Gordon DF; Wood WM; Brown NS; Bauer CA; Garrity MJ; Kleinschmidt-DeMasters BK; Lillehei KO; Samuels MH; Bright TM; Ridgway EC
Pituitary; 1999 Nov; 2(3):217-24. PubMed ID: 11081157
[TBL] [Abstract][Full Text] [Related]
6. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
Sanno N; Teramoto A; Matsuno A; Osamura RY
Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
[TBL] [Abstract][Full Text] [Related]
7. Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.
Jastania RA; Alsaad KO; Al-Shraim M; Kovacs K; Asa SL
Endocr Pathol; 2005; 16(3):187-94. PubMed ID: 16299401
[TBL] [Abstract][Full Text] [Related]
8. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
[TBL] [Abstract][Full Text] [Related]
9. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
[TBL] [Abstract][Full Text] [Related]
10. [Pathology of functioning pituitary adenomas with emphasis on the immunohistochemical classification (author's transl)].
Teramoto A
No To Shinkei; 1981 May; 33(5):479-88. PubMed ID: 6266441
[No Abstract] [Full Text] [Related]
11. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
DeStephano DB; Lloyd RV; Pike AM; Wilson BS
Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
[TBL] [Abstract][Full Text] [Related]
14. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenomas: clinicopathological and immunohistochemical study.
Martinez AJ; Lee A; Moossy J; Maroon JC
Ann Neurol; 1980 Jan; 7(1):24-36. PubMed ID: 6244771
[No Abstract] [Full Text] [Related]
16. Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.
Kobayashi I; Oka H; Naritaka H; Sato Y; Fujii K; Kameya T
Endocr Pathol; 2002; 13(2):83-98. PubMed ID: 12165656
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
Saeger W; Koch A
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of GH-producing adenomas--with special emphasis on plurihormonality of individual tumor cells by double staining.
Inada K; Oda K; Utsunomiya H; Itoh J; Osamura RY
Tokai J Exp Clin Med; 1992 Dec; 17(5-6):213-22. PubMed ID: 1285309
[TBL] [Abstract][Full Text] [Related]
19. Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.
Tordjman KM; Greenman Y; Ram Z; Hershkovitz D; Aizenstein O; Ariel O; Asa SL
Endocr Pathol; 2019 Mar; 30(1):74-80. PubMed ID: 30610567
[TBL] [Abstract][Full Text] [Related]
20. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
